Implementation of an inpatient hyperglycemia management program incorporating a nurse consultant


Por: Maria, MAM, Ramos, A, Roldan, MJM, Gimenez, IP, Perez, A

Publicada: 1 ago 2020
Resumen:
Background and aims: The efficacy and safety of inpatient hyperglycemia management protocols using basal-bolus regimens have been widely demonstrated, but their implementation is insufficient. The aim of the study was to assess implementation and to establish the efficacy and safety of inpatient hyperglycemia management protocol based on a basal-bolus regimen and the incorporation of a nurse consultant. Material and methods: Evaluation was performed at 10 hospital units. Data were retrospectively reviewed during hospital stay and 90 days after discharge in 400 patients after protocol implementation and 200 patients before implementation. The degree of satisfaction of professionals was assessed using a questionnaire 12 months after implementation. Results: The proportion of patients with basal-bolus regimens upon admission was higher in the postimplementation group (58% vs. 9%, P< 0.001). Mean pre-prandial and bedtime blood glucose levels during admission were lower in the postimplementation group (164 +/- 41 mg/L vs. 196 +/- 50 mg/dL, P<0.001). After implementation, there were less patients with blood glucose levels > 300 mg/dL (36.3% vs. 50.5%, P< 0.001) and more patients with values < 70 mg/dL (15% vs. 9%, P=0.040). Insulin addition and intensification was the main change in treatment at discharge, and a significant HbAlc reduction was seen three months after discharge in the postimplementation phase (P=0.04). The professionals assigned the protocol a score of 4.5 on a 1 to 5 scale. Conclusions: Incorporation of a nurse consultant expert in diabetes as key component of a hyperglycemia management program ensures that a majority of patients admitted to hospital for hyperglycemia receive treatment with a basal-bolus regimen and improves blood glucose control during hospital stay and after discharge. (C) 2019 SEEN y SED. Published by Elsevier Espana, S.L.U. All rights reserved.

Filiaciones:
Maria, MAM:
 Hosp Santa Creu & Sant Pau, Serv Endocrinol & Nutr, Barcelona, Spain

Ramos, A:
 Hosp Santa Creu & Sant Pau, Serv Endocrinol & Nutr, Barcelona, Spain

Roldan, MJM:
 Hosp Santa Creu & Sant Pau, Serv Endocrinol & Nutr, Barcelona, Spain

Gimenez, IP:
 Hosp Santa Creu & Sant Pau, Serv Endocrinol & Nutr, Barcelona, Spain

Perez, A:
 Hosp Santa Creu & Sant Pau, Serv Endocrinol & Nutr, Barcelona, Spain

 Univ Autonoma Barcelona, Dept Med, Bellaterra, Spain

 CIBER Diabet & Enfermedades Metab Asociadas CIBER, Barcelona, Spain
ISSN: 25300164





Endocrinologia Diabetes y Nutricion
Editorial
ELSEVIER, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, España
Tipo de documento: Article
Volumen: 67 Número: 7
Páginas: 461-468
WOS Id: 000565831600001
ID de PubMed: 31706975

MÉTRICAS